Ribociclib as First-Line Therapy for HR-Positive, Advanced...

  • Main
  • 2016 / 10
  • Ribociclib as First-Line Therapy for HR-Positive, Advanced...
New England Journal of Medicine 2016 / 10

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Hortobagyi, Gabriel N., Stemmer, Salomon M., Burris, Howard A., Yap, Yoon-Sim, Sonke, Gabe S., Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L., André, Fabrice, Winer, Eric P., Janni, Wolf
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
New England Journal of Medicine
DOI:
10.1056/NEJMoa1609709
Date:
October, 2016
File:
PDF, 288 KB
english, 2016
Conversion to is in progress
Conversion to is failed